Literature DB >> 4343748

Immunocytology of cultured IgM-forming cells of mouse. I. Requirement of phagocytic cell factor for the growth of IgM-forming tumor cells in tissue culture.

Y Namba, M Hanaoka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4343748

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  11 in total

Review 1.  New concepts in the pathogenesis of primary and secondary amyloid disease.

Authors:  M A Scheinberg; E S Cathcart
Journal:  Clin Exp Immunol       Date:  1978-07       Impact factor: 4.330

2.  Primary bioassay of human myeloma stem cells.

Authors:  A Hamburger; S E Salmon
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

Review 3.  The human tumor cloning assay in cancer drug development. A review.

Authors:  P Agre; T E Williams
Journal:  Invest New Drugs       Date:  1983       Impact factor: 3.850

4.  In vitro culture of primary plasmacytomas requires stromal cell feeder layers.

Authors:  A Degrassi; D M Hilbert; S Rudikoff; A O Anderson; M Potter; H G Coon
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

5.  Inhibition of lymphocyte mitogenesis by factor(s) released from macrophages isolated from ascitic fluid of advanced ovarian cancer patients.

Authors:  B Sheid; J Boyce
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

6.  IgG1 plasmacytosis in interleukin 6 transgenic mice.

Authors:  S Suematsu; T Matsuda; K Aozasa; S Akira; N Nakano; S Ohno; J Miyazaki; K Yamamura; T Hirano; T Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

7.  Establishment of two interleukin 6 (B cell stimulatory factor 2/interferon beta 2)-dependent human bone marrow-derived myeloma cell lines.

Authors:  S Shimizu; R Yoshioka; Y Hirose; S Sugai; J Tachibana; S Konda
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

8.  Differential stimulation of murine lymphoma growth in vitro by normal and BCG-activated macrophages.

Authors:  C F Nathan; W D Terry
Journal:  J Exp Med       Date:  1975-10-01       Impact factor: 14.307

9.  Long-term establishment of a human plasmacyte cell line derived from a patient with IgD multiple myeloma. I. Requirement of a plasmacyte-stimulating factor for the proliferation of myeloma cells in tissue culture.

Authors:  M E Jobin; J L Fahey; Z Price
Journal:  J Exp Med       Date:  1974-08-01       Impact factor: 14.307

10.  Interleukin-HP1, a T cell-derived hybridoma growth factor that supports the in vitro growth of murine plasmacytomas.

Authors:  J Van Snick; A Vink; S Cayphas; C Uyttenhove
Journal:  J Exp Med       Date:  1987-03-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.